Notizie e Video - AMERICAN RENAL ASSOCIATES HLD.

American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and operating results for the third quarter ended September 30, 2020. Certain metrics, including those expressed on an adjusted basis, are Non-GAAP financial measures (See “Use of Non-GAAP Financial Measures” and the reconciliation tables further below). Third Quarter 2020 Highlights (all percentage...

American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or the “Company”), a leading provider of outpatient dialysis services, today announced that it has entered into a definitive agreement to be acquired by Innovative Renal Care, LLC (“IRC”), an affiliate of Nautic Partners, LLC (“Nautic”), a middle market private equity firm, in an all-cash transaction that values the Company at an aggregate enterprise valuation of approximately $853 million excluding non-controlling...

American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading provider of outpatient dialysis services, is pleased to announce that the Company has received preliminary approval of the settlement of a stockholder derivative action brought by Plaintiff Luke Johnson, and pending in the United States District Court for the District of New Jersey (case number No. 19-cv-15812) (the “Johnson Action”). The proposed settlement releases all claims asserted against the Company...

American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and operating results for the second quarter ended June 30, 2020. The Company also provided an update on its COVID-19 impact and affirmed its 2020 Adjusted EBITDA less noncontrolling interests (“Adjusted EBITDA-NCI”) Outlook. These updates are highlighted later in this release. Certain metrics,...

American Renal Associates Holdings, Inc. (NYSE: ARA), a leading kidney care and dialysis services provider focused on partnering with local nephrologists, announced today that it will release its second quarter 2020 earnings results after the market close on Monday, August 10, 2020, to be followed by a conference call on Tuesday, August 11, 2020 at 9:00 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing (877) 407-8029, or for international callers (201)...

American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and operating results for the first quarter ended March 31, 2020. The Company also provided an update on its COVID-19 impact and announced that it updated its 2020 Outlook for Adjusted EBITDA-NCI. These updates are highlighted later in this release. Certain metrics, including those expressed on an adjusted...

American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced that Christopher J. Hocevar has been appointed to join the Company’s board of directors and that Steve M. Silver, who has served on ARA’s board for a number of years, has transitioned his board seat to Jeremy W. Gelber, M.D. With these changes, the Company’s board has 10 members and new board members who bring...

American Renal Associates Holdings, Inc. (NYSE: ARA), a leading kidney care and dialysis services provider focused on partnering with local nephrologists, announced today that it will release its first quarter 2020 earnings results after the market close on Monday, May 11, 2020, to be followed by a conference call on Tuesday, May 12, 2020 at 9:00 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing (877) 407-8029, or for international callers (201) 689-8029. A...

American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and operating results for the quarter and year ended December 31, 2019. The Company also announced that Joseph (Joe) Carlucci has communicated his intention to retire as Chief Executive Officer of the Company by the end of 2020. The Board of Directors will initiate a process to identify a successor for Mr....

American Renal Associates Holdings, Inc. (NYSE: ARA), a leading kidney care and dialysis provider focused on partnering with local nephrologists, announced today that it will hold its fourth quarter 2019 earnings conference call on Monday, March 16, 2020 at 5:00 p.m. (Eastern Time). The company plans to release its results after market close the same day. The conference call can be accessed live over the phone by dialing (877) 407-8029, or for international callers (201) 689-8029. A replay will...

American Renal Associates Holdings, Inc. (NYSE: ARA), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced that it will release its third quarter 2019 financial results after the market close on Tuesday, November 5, 2019, to be followed by a conference call on Wednesday, November 6, 2019 at 9:00 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing (877) 407-8029, or for international callers (201) 689-8029....

American Renal Associates Holdings, Inc. (“ARA” or the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced that it has filed with the Securities and Exchange Commission (“SEC”) its Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “2018 Annual Report”). In addition, the Company has filed its Quarterly Reports on Form 10-Q for the first and second fiscal quarters ended March 31, 2019 and...

ARA CLASS ACTION ALERT: Rosen Law Firm Reminds American Renal Associates Holdings, Inc. Investors of Important May 28th Deadline in Securities Class Action - ARA PR Newswire NEW YORK, May 17, 2019 NEW YORK , May 17, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of American Renal Associates Holdings, Inc. from August 10, 2016 through March 27, 2019 , inclusive (the "Class Period") of the May 28, 2019 lead plaintiff deadline in the...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in American Renal Associates Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline - ARA PR Newswire NEW YORK, May 14, 2019 NEW YORK , May 14, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against American Renal Associates Holdings, Inc. ("American Renal" or the "Company") (NYSE: ARA) and certain of its officers and directors. The class action, filed in...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in American Renal Associates Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline - ARA PR Newswire NEW YORK, May 14, 2019 NEW YORK , May 14, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against American Renal Associates Holdings, Inc. ("American Renal" or the "Company") (NYSE: ARA) and certain of its officers and directors. The class action, filed in...

AMERICAN RENAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against American Renal Associates Holdings, Inc. - ARA PR Newswire NEW ORLEANS, April 5, 2019 NEW ORLEANS , April 5, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana , Charles C. Foti, Jr. , remind investors that they have until May 27, 2019 to...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In American Renal Associates Holdings, Inc. To Contact The Firm PR Newswire NEW YORK, April 4, 2019 NEW YORK , April 4, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in American Renal Associates Holdings, Inc. ("American Renal" or the "Company")(NYSE: ARA) of the May 27, 2019 deadline to seek the role of lead plaintiff in...

Investor Alert: Kaplan Fox Announces Investigation Of American Renal Associates Holdings PR Newswire NEW YORK, April 3, 2019 NEW YORK , April 3, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) is investigating claims on behalf of investors of American Renal Associates Holdings, Inc. ("American Renal" or the "Company") (NYSE: ARA), a company that through its subsidiaries owns and operates kidney dialysis centers. A complaint has been filed in the United States District...

INVESTOR ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against American Renal Associates Holdings, Inc. - ARA PR Newswire NEW YORK, April 2, 2019 NEW YORK , April 2, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of American Renal Associates Holdings, Inc. (NYSE: ARA) from August 10, 2016 through March 27, 2019 , inclusive (the "Class Period"). The lawsuit seeks to...

RM LAW Announces Class Action Lawsuit Against American Renal Associates Holdings, Inc. PR Newswire BERWYN, Pa., April 2, 2019 BERWYN, Pa. , April 2, 2019 /PRNewswire/ -- RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased American Renal Associates Holdings, Inc. ("American Renal" or the "Company") (NYSE: ARA) between August 10, 2016 and March 27, 2019 , inclusive (the "Class Period"). American Renal shareholders may, no later than...